Test Catalog

Test ID: 23BPG    
2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine

Useful For Suggests clinical disorders or settings where the test may be helpful

Screening for mast cell activation disorders including systemic mastocytosis


2,3-Dinor-11beta-prostaglandin F2 alpha (2,3 BPG) is elevated in the urine of patients with systemic mastocytosis (SM).


2,3 BPG should be used as a screening test for systemic mastocytosis.


When 2,3 BPG is used in combination with urinary leukotriene E4 (LTE4) and N-methyl histamine (NMH), the sensitivity for SM detection increases to 90%.

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

When this test is performed, urine creatinine will always be performed at no additional charge.

Special Instructions Library of PDFs including pertinent information and forms related to the test

Method Name A short description of the method used to perform the test

23BPG: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

AACT: Enzymatic Colorimetric Assay

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

2,3-dinor 11B-Prostaglandin F2a, U

Aliases Lists additional common names for a test, as an aid in searching

2,3 11 Beta-Prostaglandin F2 Alpha
11 Beta-Prostaglandin F2 Alpha